Keryx Biopharma (KERX) Files $100M Mixed Securities Shelf
- Wall St. slumps as weak China data stokes growth fears
- Pre-Open Stock Movers 09/01: (TRVN) (KTOS) (ALKS) Higher; (ADEP) (DLTR) (GPRO) Lower (more...)
- General Motors (GM) U.S. Sales Fell Less than Expected in August
- Apple (AAPL) Said Planning to Produce Original Video Content (NFLX)
- Deutsche Bank Upgrades American Airlines (AAL), Delta (DAL), and Copa (CPA) to Buy
Keryx Biopharma (Nasdaq: KERX) filed for a $100 million mixed securities shelf.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Carolina Financial (CARO) Files $50M Mixed Shelf
- Oaktree Capital Group (OAK) Files 105.3M Unit Shelf
- Nobilis Health (HLTH) Files Common Shares, Warrants Shelf
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!